Predicting Molecular Phenotypes with Single Cell RNA Sequencing: An Assessment of Unsupervised Machine Learning Models
ISEF · 2021 Computational Biology and Bioinformatics
Overview
The National Cancer Institute reported 9.5 million cancer-related deaths in 2018. A challenge in improving treatment is resistance in genetically unstable cells. The purpose of this study is to evaluate unsupervised machine learning on classification of treatment-resistant phenotypes in heterogeneous tumors through single cell RNA sequencing (scRNAseq) data analysis with a unique pipeline and innovative evaluation metrics. scRNAseq quantifies mRNA in cells and characterizes cell phenotypes. Two scRNAseq datasets were analyzed: cells of different cell phases (S, G1, G2/M) and tumor/non-tumor cells of different molecular subtypes. Accurately identifying these cells is vital because irregular cell cycles may fail to respond to treatment, and tumor cell subtypes may have resistant phenotypes. The pipeline consists of data filtering, dimensionality reduction with Principal Component Analysis, projection with Uniform Manifold Approximation and Projection, clustering with nine methods (Ward, BIRCH, Gaussian Mixture, DBSCAN, Spectral, Affinity Propagation, Agglomerative, Mean Shift, K-Means), and evaluation. Six models divided G2 v. S cells; Spectral, Ward, and K-Means ranked highest with ~60% accuracy. Seven models divided tumor v. non-tumor cells; K-Means, Ward, and BIRCH ranked highest with ~80% accuracy. Because Ward and K-Means ranked high in both tasks, analysis was optimized by using these models; three subtypes in the identified tumor cell population were discovered, verifying the efficacy of unsupervised analysis in tumor heterogeneity research. In clinical settings where there is no standard scRNAseq analysis protocol, this pipeline can be used to generate clusters that hold key information about the tumor microenvironment, directly affecting the success of treatment.
Competition history
- ISEF 2021
Resources
Related projects
ISEF · 2023
Integrating Machine Learning with 3D Organoid Modeling to Identify Biomarkers to Combat Drug Resistance in Cancer
ISEF · 2022
Two Novel Single-cell Algorithms Elucidate the Therapeutic Potential of Clinically-relevant Small-molecule Inhibitors for Targeting Cancer Metastasis
ISEF · 2021
Predicting Cancer Stem Cell Biomarkers with Machine Learning
ISEF · 2016
Drug Vulnerabilities of the Cancer Cell Line Encyclopedia Are Revealed by Machine Learning Approaches
Closest projects by meaning, across every fair and year in the corpus.
Source: Regeneron International Science and Engineering Fair